Pluri in talks with EIB on €20M loan maturity

Pluri Inc. is in ongoing discussions with the European Investment Bank (EIB) over its existing loan.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Pluri Inc. is in ongoing discussions with the European Investment Bank (EIB) over its existing loan. The EIB finance agreement provides for up to €50 million, of which the first €20 million tranche was drawn in June 2021 at 4% interest and was scheduled to mature on June 1, 2026.

On May 28, 2026, the EIB told Pluri that the parties remain in constructive, good-faith negotiations to reach a mutually agreed resolution regarding this €20 million EIB Loan. The EIB indicated it does not currently contemplate enforcement actions while talks continue and expects discussions not to extend beyond July 3, 2026.

The EIB has reserved all rights and may act if negotiations do not lead to an outcome it finds acceptable. Pluri cautions that there is no assurance of a mutually acceptable resolution or continued forbearance, and highlights broader risks including its liquidity position and need for additional financing.

Insights

Pluri faces near-term loan maturity talks with EIB and limited standstill.

The company has a €20 million tranche outstanding under a finance agreement with the European Investment Bank, bearing 4% interest and originally due on June 1, 2026. Both sides remain in “constructive” good-faith discussions over how to handle this maturity.

The EIB has said negotiations are not expected to extend beyond July 3, 2026 and that no enforcement action is currently contemplated while talks continue. However, it has explicitly reserved all rights, including remedies under the finance agreement, if it does not accept the eventual outcome.

Pluri points to risks around the loan outcome, its liquidity position, and need for additional financing. Subsequent company filings may show whether the parties agree on an extension, restructuring, or other solution, or whether the EIB chooses to exercise its remedies after the negotiation period.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

Total EIB facility size: €50 million Disbursed EIB tranche: €20 million EIB Loan interest rate: 4% per annum +2 more

5 metrics

Total EIB facility size €50 million Maximum funding under finance agreement

Disbursed EIB tranche €20 million First tranche drawn in June 2021

EIB Loan interest rate 4% per annum Applies to €20 million tranche

Scheduled maturity date June 1, 2026 Original repayment date for EIB Loan

Negotiation period end July 3, 2026 EIB does not expect talks to extend beyond this date

Key Terms

finance agreement, European Investment Bank, enforcement action, remedies, +2 more

6 terms

finance agreement financial

"entered into a finance agreement with the European Investment Bank"

European Investment Bank financial

"entered into a finance agreement with the European Investment Bank"

enforcement action regulatory

"no enforcement action is currently contemplated while discussions remain ongoing"

remedies regulatory

"the right to take action should the discussions not result in an outcome acceptable to the EIB"

liquidity position financial

"the Company’s liquidity position and need for additional financing"

Liquidity position describes how much cash and easily converted-into-cash assets an organization has relative to its upcoming bills and obligations. Think of it like a household’s checking account and emergency fund: it shows whether the business can pay short-term costs, cover debt and handle surprises without selling long-term investments. Investors care because a stronger liquidity position reduces the risk of bankruptcy, supports operations and gives flexibility for opportunities or downturns.

forward-looking statements regulatory

"contains express or implied forward-looking statements within the meaning"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the size and status of Pluri (PLUR) European Investment Bank loan?

Pluri has an EIB finance agreement for up to €50 million, with a €20 million first tranche drawn in June 2021 at 4% interest. That €20 million EIB Loan was scheduled to become repayable on June 1, 2026, and is now subject to ongoing negotiations.

What did the European Investment Bank communicate to Pluri (PLUR) on May 28, 2026?

On May 28, 2026, the EIB confirmed that it and Pluri remain in constructive, good-faith discussions to reach a mutually agreed resolution regarding the €20 million EIB Loan. It also indicated discussions and negotiations are not expected to extend beyond July 3, 2026.

Is the European Investment Bank currently enforcing remedies against Pluri (PLUR)?

The EIB stated that, during the ongoing negotiation period through around July 3, 2026, no enforcement action is currently contemplated while discussions continue. However, it reserved all rights and may take action if talks do not produce an outcome acceptable to the EIB.

What risks does Pluri (PLUR) highlight regarding the EIB Loan discussions?

Pluri notes there is no assurance the parties will reach a mutually acceptable resolution or that the EIB will keep refraining from exercising remedies. It also cites broader risks, including its liquidity position, need for additional financing, and general market and economic conditions.

When are EIB loan negotiations with Pluri (PLUR) expected to conclude?

The EIB advised Pluri that discussions and negotiations over the €20 million EIB Loan are not expected to extend beyond July 3, 2026. This date effectively sets a target window for concluding talks, after which the EIB may decide whether to exercise any available remedies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/01/2026 - 04:06 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 1, 2026 (May 28, 2026)

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada		001-31392		98-0351734
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

MATAM Advanced Technology Park
Building No. 5
Haifa, Israel		3508409
(Address of Principal Executive Offices)		(Zip Code)

011 972 74 710 7171

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Shares, par value $0.00001 per share		PLUR		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

As previously disclosed, Pluri Inc. (the “Company”), together with its subsidiaries, Pluri Biotech Ltd., incorporated under the laws of Israel, and Pluristem GmbH, incorporated under the laws of Germany, entered into a finance agreement with the European Investment Bank (“EIB”) providing for up to €50 million in funding, of which only the first tranche of €20 million was disbursed in June 2021, and such amount bears interest at 4% per annum, and was scheduled to become repayable on June 1, 2026 (the “EIB Loan”). The Company also previously disclosed that on April 21, 2026, the Company received notice from the EIB that the EIB was reserving all of its rights under the finance agreement while discussions concerning potential alternatives, including a possible extension of the maturity date, remained ongoing.

On May 28, 2026, the EIB confirmed to the Company that the parties remain engaged in constructive discussions in good faith with the objective of exploring a mutually agreed resolution regarding the EIB Loan. The EIB further advised that such discussions and negotiations are not expected to extend beyond July 3, 2026, and that during that period, and without prejudice to any of the EIB’s rights and remedies, no enforcement action is currently contemplated while discussions remain ongoing. The EIB reserved all rights, including the right to take action should the discussions not result in an outcome acceptable to the EIB. No assurance can be given that the parties will reach a mutually acceptable resolution or that the EIB will continue to refrain from exercising remedies available to it under the finance agreement.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements regarding discussions with the EIB, and the potential resolution of matters relating to the EIB Loan. Words such as “may”, “will”, “should”, “could”, “would”, “expect”, “intend”, “plan”, “believe”, “estimate”, “target”, “potential”, “continue”, “anticipate”, “seek”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Risks and uncertainties include, among others, the outcome and timing of the Company’s discussions with the EIB regarding the EIB Loan, whether those discussions result in a mutually agreed resolution, the Company’s liquidity position and need for additional financing, general market and economic conditions, the possibility that the EIB may exercise remedies under the finance agreement and other risks and uncertainties described under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in other filings the Company makes with the U.S. Securities and Exchange Commission (the “SEC”). Forward-looking statements speak only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PLURI INC.

Date: June 1, 2026	By:	/s/ Liat Zalts
	Name:	Liat Zalts
	Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Pluri in talks with EIB on €20M loan maturity

Rhea-AI Filing Summary